Selection and Identification of Skeletal-Muscle-Targeted RNA Aptamers
Oligonucleotide gene therapy has shown great promise for the treatment of muscular dystrophies. Nevertheless, the selective delivery to affected muscles has shown to be challenging because of their high representation in the body and the high complexity of their cell membranes. Current trials show l...
Main Authors: | Styliana Philippou, Nikolaos P. Mastroyiannopoulos, Neoklis Makrides, Carsten W. Lederer, Marina Kleanthous, Leonidas A. Phylactou |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-03-01
|
Series: | Molecular Therapy: Nucleic Acids |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253117303025 |
Similar Items
-
Selective Delivery to Cardiac Muscle Cells Using Cell-Specific Aptamers
by: Styliana Philippou, et al.
Published: (2023-09-01) -
Selection and identification of a novel ssDNA aptamer targeting human skeletal muscle
by: Shuming Sun, et al.
Published: (2023-02-01) -
The Shorter the Better: Reducing Fixed Primer Regions of Oligonucleotide Libraries for Aptamer Selection
by: Weihua Pan, et al.
Published: (2009-03-01) -
Skeletal muscle in health and disease
by: Jennifer Morgan, et al.
Published: (2020-02-01) -
Design and Prediction of Aptamers Assisted by In Silico Methods
by: Su Jin Lee, et al.
Published: (2023-01-01)